Birdwatch Note
2023-03-19 20:35:23 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Eli Lilly & Co. announced plans earlier this month to reduce the price of its insulin products as much as 70%. Novo Nordisk made a similar announcement to cap out-of-pocket costs this week and Sanofi followed suit Thursday. https://www.latimes.com/california/story/2023-03-18/newsom-announces-50m-contract-to-make-californias-own-brand-of-insulin#:~:text=With%20FDA%20approval%2C%20the%20contract,delivery%20is%20made%2C%20Newsom%20said.
Written by 7AB66594675C03DA6E48D83FC3D5DC0B9E5028704E93DE191034E86E0E995263
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1637544471377092608
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1637553373233790979
- noteId - 1637553373233790979
- participantId -
- noteAuthorParticipantId - 7AB66594675C03DA6E48D83FC3D5DC0B9E5028704E93DE191034E86E0E995263 Participant Details
- createdAtMillis - 1679258123107
- tweetId - 1637544471377092608
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Eli Lilly & Co. announced plans earlier this month to reduce the price of its insulin products as much as 70%. Novo Nordisk made a similar announcement to cap out-of-pocket costs this week and Sanofi followed suit Thursday. https://www.latimes.com/california/story/2023-03-18/newsom-announces-50m-contract-to-make-californias-own-brand-of-insulin#:~:text=With%20FDA%20approval%2C%20the%20contract,delivery%20is%20made%2C%20Newsom%20said.
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-03-19 20:35:23 UTC (1679258123107) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-20 03:10:48 UTC (1679281848093) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-03-19 19:20:43 -0500 | Rating Details | |
2023-03-19 19:08:34 -0500 | Rating Details | |
2023-03-19 18:51:49 -0500 | Rating Details | |
2023-03-19 18:37:51 -0500 | Rating Details | |
2023-03-19 18:35:29 -0500 | Rating Details | |
2023-03-19 18:06:08 -0500 | Rating Details | |
2023-03-19 17:58:13 -0500 | Rating Details | |
2023-03-19 17:54:34 -0500 | Rating Details | |
2023-03-19 17:50:59 -0500 | Rating Details | |
2023-03-19 17:41:37 -0500 | Rating Details | |
2023-03-19 17:37:14 -0500 | Rating Details | |
2023-03-19 17:36:03 -0500 | Rating Details | |
2023-03-19 17:24:50 -0500 | Rating Details | |
2023-03-19 17:08:50 -0500 | Rating Details | |
2023-03-19 17:05:49 -0500 | Rating Details | |
2023-03-19 16:54:16 -0500 | Rating Details | |
2023-03-19 16:51:49 -0500 | Rating Details | |
2023-03-19 16:51:16 -0500 | Rating Details | |
2023-03-19 16:15:32 -0500 | Rating Details | |
2023-03-19 16:14:04 -0500 | Rating Details | |
2023-03-19 16:10:08 -0500 | Rating Details | |
2023-03-19 16:01:32 -0500 | Rating Details | |
2023-03-19 15:59:45 -0500 | Rating Details | |
2023-03-19 15:47:37 -0500 | Rating Details | |
2023-03-19 15:47:09 -0500 | Rating Details | |
2023-03-19 15:41:53 -0500 | Rating Details | |
2023-03-19 15:41:17 -0500 | Rating Details | |
2023-03-19 15:40:27 -0500 | Rating Details | |
2023-03-20 19:00:54 -0500 | Rating Details | |
2023-03-20 17:24:00 -0500 | Rating Details | |
2023-03-20 12:38:22 -0500 | Rating Details | |
2023-03-20 11:51:39 -0500 | Rating Details | |
2023-03-20 11:49:43 -0500 | Rating Details | |
2023-03-20 10:18:48 -0500 | Rating Details | |
2023-03-20 10:12:20 -0500 | Rating Details | |
2023-03-20 10:09:21 -0500 | Rating Details | |
2023-03-20 09:53:44 -0500 | Rating Details | |
2023-03-20 09:53:31 -0500 | Rating Details | |
2023-03-20 09:53:31 -0500 | Rating Details | |
2023-03-20 09:30:47 -0500 | Rating Details | |
2023-03-20 08:23:04 -0500 | Rating Details | |
2023-03-20 08:16:22 -0500 | Rating Details | |
2023-03-20 08:03:00 -0500 | Rating Details | |
2023-03-20 07:34:27 -0500 | Rating Details | |
2023-03-20 06:41:25 -0500 | Rating Details | |
2023-03-20 06:35:56 -0500 | Rating Details | |
2023-03-20 06:26:02 -0500 | Rating Details | |
2023-03-20 06:25:59 -0500 | Rating Details | |
2023-03-20 06:16:03 -0500 | Rating Details | |
2023-03-20 06:12:31 -0500 | Rating Details | |
2023-03-20 06:08:10 -0500 | Rating Details | |
2023-03-20 03:36:25 -0500 | Rating Details | |
2023-03-20 01:11:55 -0500 | Rating Details | |
2023-03-20 00:18:25 -0500 | Rating Details | |
2023-03-19 23:43:18 -0500 | Rating Details | |
2023-03-19 23:41:16 -0500 | Rating Details | |
2023-03-19 23:11:32 -0500 | Rating Details | |
2023-03-19 22:54:49 -0500 | Rating Details | |
2023-03-19 22:45:31 -0500 | Rating Details | |
2023-03-19 22:40:46 -0500 | Rating Details | |
2023-03-19 22:26:28 -0500 | Rating Details | |
2023-03-19 22:21:11 -0500 | Rating Details | |
2023-03-19 21:32:42 -0500 | Rating Details | |
2023-03-19 21:12:38 -0500 | Rating Details | |
2023-03-19 21:06:08 -0500 | Rating Details | |
2023-03-19 20:40:06 -0500 | Rating Details | |
2023-03-19 20:26:28 -0500 | Rating Details | |
2023-03-19 19:56:10 -0500 | Rating Details | |
2023-03-23 13:39:35 -0500 | Rating Details | |
2023-03-20 06:35:56 -0500 | Rating Details | |
2023-03-19 23:43:18 -0500 | Rating Details | |
2023-03-19 15:41:17 -0500 | Rating Details | |
2023-03-19 15:47:09 -0500 | Rating Details | |
2023-03-19 16:54:16 -0500 | Rating Details | |
2023-03-20 09:53:44 -0500 | Rating Details | |
2023-03-20 06:26:02 -0500 | Rating Details | |
2023-03-19 20:26:28 -0500 | Rating Details | |
2023-03-19 15:47:37 -0500 | Rating Details | |
2023-03-19 17:54:34 -0500 | Rating Details | |
2023-03-20 06:12:31 -0500 | Rating Details | |
2023-03-19 17:08:50 -0500 | Rating Details | |
2023-03-19 16:15:32 -0500 | Rating Details | |
2023-03-19 21:12:38 -0500 | Rating Details | |
2023-03-20 06:41:25 -0500 | Rating Details | |
2023-03-20 00:18:25 -0500 | Rating Details | |
2023-03-20 08:23:04 -0500 | Rating Details | |
2023-03-20 03:36:25 -0500 | Rating Details | |
2023-03-20 12:38:22 -0500 | Rating Details | |
2023-03-19 19:20:43 -0500 | Rating Details | |
2023-03-19 17:41:37 -0500 | Rating Details | |
2023-03-19 17:50:59 -0500 | Rating Details | |
2023-03-19 19:56:10 -0500 | Rating Details | |
2023-03-20 06:08:10 -0500 | Rating Details | |
2023-03-20 11:49:43 -0500 | Rating Details | |
2023-03-19 15:59:45 -0500 | Rating Details | |
2023-03-20 09:53:31 -0500 | Rating Details | |
2023-03-19 17:05:49 -0500 | Rating Details | |
2023-03-20 08:16:22 -0500 | Rating Details | |
2023-03-20 10:09:21 -0500 | Rating Details | |
2023-03-19 16:01:32 -0500 | Rating Details | |
2023-03-19 18:06:08 -0500 | Rating Details | |
2023-03-19 22:21:11 -0500 | Rating Details | |
2023-03-19 17:58:13 -0500 | Rating Details | |
2023-03-19 22:54:49 -0500 | Rating Details | |
2023-03-19 15:40:27 -0500 | Rating Details | |
2023-03-20 11:51:39 -0500 | Rating Details | |
2023-03-19 23:11:32 -0500 | Rating Details | |
2023-03-19 17:37:14 -0500 | Rating Details | |
2023-03-19 17:24:50 -0500 | Rating Details | |
2023-03-19 20:40:06 -0500 | Rating Details | |
2023-03-20 06:25:59 -0500 | Rating Details | |
2023-03-23 13:39:35 -0500 | Rating Details | |
2023-03-19 18:37:51 -0500 | Rating Details | |
2023-03-20 09:30:47 -0500 | Rating Details | |
2023-03-20 10:12:20 -0500 | Rating Details | |
2023-03-19 23:41:16 -0500 | Rating Details | |
2023-03-19 18:35:29 -0500 | Rating Details | |
2023-03-19 22:45:31 -0500 | Rating Details | |
2023-03-19 17:36:03 -0500 | Rating Details | |
2023-03-20 06:16:03 -0500 | Rating Details | |
2023-03-20 19:00:54 -0500 | Rating Details | |
2023-03-19 19:08:34 -0500 | Rating Details | |
2023-03-19 16:14:04 -0500 | Rating Details | |
2023-03-19 22:26:28 -0500 | Rating Details | |
2023-03-19 16:51:16 -0500 | Rating Details | |
2023-03-19 18:51:49 -0500 | Rating Details | |
2023-03-20 17:24:00 -0500 | Rating Details | |
2023-03-19 16:51:49 -0500 | Rating Details | |
2023-03-19 15:41:53 -0500 | Rating Details | |
2023-03-20 10:18:48 -0500 | Rating Details | |
2023-03-19 21:06:08 -0500 | Rating Details | |
2023-03-19 16:10:08 -0500 | Rating Details | |
2023-03-20 08:03:00 -0500 | Rating Details | |
2023-03-19 21:32:42 -0500 | Rating Details | |
2023-03-20 09:53:31 -0500 | Rating Details | |
2023-03-20 01:11:55 -0500 | Rating Details | |
2023-03-20 07:34:27 -0500 | Rating Details |